🇺🇸 FDA
Patent

US 9611292

Peptide inhibitors of serotonin 5-HT2c receptors:PTEN interaction

granted A61KA61K38/00A61K38/08

Quick answer

US patent 9611292 (Peptide inhibitors of serotonin 5-HT2c receptors:PTEN interaction) held by The Board of Regents of the University of Texas System expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00, A61K38/08